8-K/A: Mobix Labs Amends Note Terms, Secures $2.15M Financing
Amendment to Current Report
Mobix Labs, Inc. filed an amendment to correct the conversion terms of a secured promissory note and detailed recent financing transactions totaling $2.15 million.
Summary
- This filing is an amendment (8-K/A) to correct an inadvertent error in the original Form 8-K filed on August 21, 2025, regarding the conversion terms of a secured promissory note issued to Lendspark.
- The correction clarifies that the Lendspark note is convertible at any time at Lendspark's option, not just upon default, into up to 2,500,000 shares of Class A Common Stock at a fixed conversion price of $0.70 per share.
- Mobix Labs, Inc. completed a series of financing transactions on August 13 and August 15, 2025, aimed at enhancing working capital and providing financial flexibility.
- A secured promissory note in the principal amount of $550,000 was issued to Lendspark Corporation, bearing a fixed annual interest rate and maturing in 12 months.
- As part of the Lendspark financing, 150,000 shares of Class A common stock were issued as commitment shares, and a first-priority security interest was granted in substantially all company assets.
- The company also entered into a Business Loan and Security Agreement with Maximcash Solutions LLC, receiving $600,000 in loan proceeds secured by all company assets.
- In connection with the Maxim financing, 93,750 shares of Class A Common Stock were issued as commitment shares, and 1,500,000 shares of Class A Common Stock were pledged as additional collateral, usable only upon default.
- An accredited investor purchased 1,052,725 shares of Class A Common Stock at $0.95 per share on August 15, 2025, generating approximately $1.0 million in gross proceeds.
- The accredited investor also received a warrant to purchase 500,045 shares of Class A common stock at an exercise price of $0.96 per share, exercisable for three years.
- The securities issued were pursuant to exemptions from registration under Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506(b) of Regulation D.
Sentiment
Score: 4
Explanation: While the company secured needed financing, the terms, particularly the immediate convertibility of the Lendspark note and the extensive asset pledges, are quite restrictive and indicate a challenging capital environment. The significant potential for dilution also weighs on the sentiment.
Positives
- Secured approximately $2.15 million in new financing, which is intended to enhance working capital and provide additional financial flexibility.
- Diversified financing sources through a mix of secured debt and an equity investment from an accredited investor.
- The equity investment at $0.95 per share indicates some level of market confidence in the company's valuation.
Negatives
- The amendment clarifies a less favorable term for the company, allowing Lendspark to convert its note into equity at any time, increasing immediate dilution risk.
- Significant potential for shareholder dilution from the issuance of 150,000 commitment shares to Lendspark, 93,750 commitment shares to Maxim, the sale of 1,052,725 shares to an accredited investor, and the potential conversion of the Lendspark note (up to 2,500,000 shares) and the exercise of warrants (500,045 shares).
- Granting first-priority security interests in substantially all company assets to Lendspark and all assets to Maxim significantly restricts future financing options and increases risk for unsecured creditors.
- The conversion price of $0.70 per share for the Lendspark note is notably lower than the $0.95 per share obtained from the accredited investor, suggesting a potentially lower valuation for the debt conversion.
Risks
- Significant potential for shareholder dilution from the conversion of the Lendspark note (up to 2,500,000 shares), the commitment shares (243,750 shares), the equity investment (1,052,725 shares), and the warrant (500,045 shares).
- The first-priority security interest granted to Lendspark and Maxim on substantially all company assets increases financial risk and limits the company's ability to secure additional debt financing without subordination.
- The make-whole provisions in the Lendspark note could require the company to issue additional shares or make cash payments under certain circumstances, adding financial obligations.
- The pledge of 1,500,000 shares to Maxim as additional collateral, usable upon default, poses a significant risk of further dilution or loss of control if the company defaults on the loan.
Future Outlook
The financing transactions are intended to enhance the company's working capital position and provide additional financial flexibility for future operations.
Management Comments
- "This Amendment No. 1 is being filed to correct an inadvertent error contained in the Original Filing relating to the conversion terms of the secured promissory note issued to Lendspark."
- "The Company completed a series of financing transactions that enhance the Company's working capital position and provide additional financial flexibility."
Industry Context
The company, operating in a capital-intensive sector, is securing financing through a mix of debt and equity, a common strategy for emerging growth companies to fund operations and expansion. The use of secured debt and convertible notes reflects the challenges smaller companies can face in accessing less dilutive or less restrictive capital.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: Face significant potential dilution from the issuance of commitment shares, the conversion of the Lendspark note, and the equity investment, which could depress per-share value.
- Creditors: Existing unsecured creditors may be disadvantaged by the first-priority security interests granted to Lendspark and Maxim over substantially all company assets.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2025-08-13 | Date of earliest event reported; Mobix Labs entered into Securities Purchase Agreement with Lendspark and completed part of financing transactions. |
| 2025-08-15 | Mobix Labs completed part of financing transactions and entered into Stock Purchase Agreement with an accredited investor. |
| 2025-08-21 | Original Form 8-K filed with the SEC. |
| 2025-09-03 | Date of signing of this Form 8-K/A. |
Recommendation
sellThe filing reveals a company in a challenging financial position, evidenced by the need for secured debt with extensive asset pledges and a convertible note with unfavorable terms (convertible at any time, below market equity price). The significant potential for dilution from multiple share issuances and warrants, coupled with the restrictive nature of the debt, suggests substantial downside risk for existing shareholders. While capital was raised, the terms indicate distress and will likely lead to further share price pressure.
Keywords
Mobix Labs, MOBX, SEC Filing, 8-K/A, Financing, Secured Promissory Note, Equity Investment, Dilution, Lendspark, Maximcash Solutions, Nasdaq Capital Market, Working Capital, Corporate Finance, Warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.